Canakinumab: Powder for injection 150 mg with solvent, Solution for injection 150 mg in 1 mL; Ilaris® Page last updated: 2 March 2018 Public Summary Document (PSD) November 2017 PBAC Meeting - (PDF 135 KB) Public Summary Document (PSD) November 2017 PBAC Meeting - (Word 42 KB)